Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Eflornithine and sulindac, fixed dose combination formulation

Eflornithine and sulindac, fixed dose combination formulation

US Patent 10973790 · Granted Apr 13, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method of producing a delayed release drug formulation2025
Coatable core for a modified release drug formulation2025
Eflornithine and sulindac, fixed dose combination formulation2025
Eflornithine and sulindac, fixed dose combination formulation2025
Eflornithine and sulindac, fixed dose combination formulation2025
Modified release coated capsules2024
Eflornithine and sulindac, fixed dose combination formulation2024
Eflornithine and sulindac, fixed dose combination formulation2024
Eflornithine and sulindac, fixed dose combination formulation2024
Topical treatment of inflammatory bowel disease using antibodies and fragments t2023
Delayed release drug formulation2022
Eflornithine and sulindac, fixed dose combination formulation2022